CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in ABBV — AbbVie Inc.
CIK 1766904
RICHMOND, VA
Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,277,835
+$507,258 QoQ
Shares Held
9,052
+11.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#1,867
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $10,872,180 across 13 Drug Manufacturers - General names. ABBV ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,853 | $3,421,967 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
9,052 | $2,277,835 | |
| 3 | JNJ |
Johnson & Johnson
|
5,727 | $1,454,479 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,104 | $1,041,359 | |
| 5 | AMGN |
Amgen Inc
|
2,175 | $787,606 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,702 | $467,705 | |
| 7 | NVS |
Novartis AG
|
2,406 | $377,067 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,072 | $349,863 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,277,835 | 9,052 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $1,770,577 | 8,141 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $1,803,467 | 7,893 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $1,635,130 | 7,062 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $1,263,880 | 6,809 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,445,891 | 6,901 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $1,115,951 | 6,280 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $25,646,723 | 129,870 | Shares | Defined | 2024-10-30 | |
| 2024-06-30 | $21,597,451 | 125,918 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $22,233,679 | 122,096 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $18,655,904 | 120,384 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $17,656,752 | 118,454 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,481,521 | 92,641 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $14,518,925 | 91,102 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,743,518 | 91,229 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,524,477 | 93,320 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,201,932 | 86,197 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,585,168 | 15,947 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,353,387 | 17,381 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,429,277 | 13,250 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,520,414 | 13,498 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $842,817 | 7,788 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,224,434 | 20,760 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,951,214 | 67,944 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $370,138 | 3,770 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $255,922 | 3,359 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||